Dados B3 › VIVT3 × CASH3 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | VIVT3 | CASH3 | year |
|---|---|---|---|
| ROE | 8.9% | -0.1% | 2025 |
| ROIC | 10.1% | 4.0%! | 2025 |
| ROA | 4.9% | -0.2% | 2025 |
| Gross margin | 44.8% | 4.2% | 2025 |
| EBIT margin | 16.5% | 4.2% | 2025 |
| Net margin | 10.4% | -0.2% | 2025 |
| Net debt/EBITDA | 0.53x | -2.40x | 2025 |
| Current ratio | 1.00x | 2.05x | 2025 |
| Revenue growth (1y) | 6.7% | 26.1% | 2025 |
| Revenue growth (5y CAGR) | 6.7% | 29.7% | 2025 |
| Piotroski F-Score | 7/9 | 5/9 | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | VIVT3 | CASH3 | year |
|---|---|---|---|
| P/E | 21.78x | -590.73x | 2025 |
| P/B | 1.95x | 0.72x | 2025 |
| EV/EBITDA | 5.95x | 7.47x | 2025 |
| FCF yield | 8.4% | -87.1% | 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 13:37 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it